NCT04949048 is a NA clinical trial of Magneto PE Kit in Pulmonary Embolism, sponsored by Magneto Thrombectomy Solutions.

Who is sponsoring NCT04949048?

NCT04949048 is sponsored by Magneto Thrombectomy Solutions.

What drugs are being tested in NCT04949048?

Interventions in NCT04949048: Magneto PE Kit.

What condition does NCT04949048 study?

NCT04949048 studies Pulmonary Embolism.

Is NCT04949048 still recruiting?

NCT04949048 is currently completed. Last updated 13 March 2024.

Last reviewed 2024-03-13 · How we verify

NCT04949048

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the Safety and Performance of Magneto PE Kit

Completed NA Last updated 13 March 2024

What this trial tests

NA trial testing Magneto PE Kit in Pulmonary Embolism in 15 participants. Completed in 21 December 2023.

Timeline

26 August 2021

Primary endpoint
22 November 2023

21 December 2023

Quick facts

Lead sponsor	Magneto Thrombectomy Solutions
Phase	NA
Status	Completed
Study type	INTERVENTIONAL
Allocation	na
Design	single group
Masking	none
Primary purpose	treatment
Enrollment	15
Start date	26 August 2021
Primary completion	22 November 2023
Estimated completion	21 December 2023
Sites	5 locations across Denmark, Israel, Poland

Drugs / interventions tested

Magneto PE Kit

Conditions studied

Pulmonary Embolism — all drugs for Pulmonary Embolism →

Sponsor

Magneto Thrombectomy Solutions

Who can join

Adults 18 to 75, any sex, with Pulmonary Embolism. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study is designed as a prospective, multi-center, multinational open labeled, single armed study to evaluate the safety and performance of the Magneto PE Kit.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Catheter-based techniques for pulmonary embolism treatment.
Costa F, Salinas P, Iannaccone M, Cerrato E, et al · · 2025 · cited 2× · PMID 40325983 · DOI 10.4244/eij-d-24-00535

Verify or expand the search:

Other recruiting trials for Pulmonary Embolism

Currently open trials in the same condition.

NCT07381712 — High-Flow Nasal Cannula Versus Non-Invasive Ventilation for Acute Respiratory Failure in Pulmonary Embolism. · NA · active not recruiting
NCT04211181 — CHIPs-VTE Study in Hospitalized Patients to Prevent Hospital-Acquired Venous Thromboembolism · NA · recruiting
NCT07003646 — Reperfusion Treatment in Acute Pulmonary Embolism · recruiting
NCT06600542 — Inari VISION Registry · recruiting
NCT06622876 — Incidental Discovery of Pulmonary Emboli Via CT Scan: Impact of Detections on Patient Care and Resulting Complications · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04949048 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Magneto Thrombectomy Solutions
Last refreshed: 13 March 2024

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04949048.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing